Endocrine Abstracts

Introduction: The BSPED UK thyrotoxicosis study has been running for 10 years. The primary objective is to assess biochemical control on block and replace (BR) and dose titration (DT) regimens. The final patient was recruited towards the end of 2011 and study will finish in 2015. We would like to describe the baseline characteristics of study patients and the initial response to anti-thyroid drug therapy (ATD).Methods: We focused on patient age, sex, BMI...